SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

Completed

• Conditions: Lung Cancer

• Registration Number: NCT01855191
• Lead Sponsor: Maastricht Radiation Oncology

Brief Summary

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

Detailed Description

All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling.

Follow up at five time points:

* 2 weeks after RT

* 3 months after RT

* 6 months after RT

* 12 months after RT

* 24 months after RT

At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.

Study Timeline

• Study First Submitted: 2013-03-26
• Study First Submitted QC: 2013-05-15
• Study First Posted: 2013-05-16
• Study Start: 2013-06
• Primary Completion: 2019-02
• Study Completion: 2019-02
• Status Verified: 2019-03
• Last Update Submitted: 2019-03-25
• Last Update Posted: 2019-03-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 864

Inclusion Criteria

• All patients planned for curatively intended radiotherapy or postoperative radiotherapy
• Recurrent disease

Exclusion Criteria

• All patients planned for palliative radiotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Two-year survival rate	24 months after RT

Secondary Outcome Measures

Name	Time	Method
Change in cough	During 24 months after RT
Change in dysphagia	During 24 months after RT
Change in dyspnea	during 24 months after RT
Patient-rated generic quality of life	During 24 months after RT	Measured by Euroqol questionnaire

Trial Locations

Locations (1)

MAASTRO clinic; 🇳🇱 Maastricht, Netherlands